Patent · US Active

Regulating Bacillus anthracis lethal factor activity via an activating epitope region

US9845349B2 · kind B2 · utility

0Cited by

1References

5Claims

0Family size

Assignee

The United States of America, as represented by the Secretary, Department of Health and Human Services · US

Inventors

Jason Goldstein · Burlingame, US
Conrad Padraig Quinn · Lilburn, US
Dennis Anthony BAGAROZZI, Jr. · Lilburn, US

Key dates

Filing date	Apr 23, 2015
Grant date	Dec 19, 2017
Priority date	—
Expiry date	Apr 23, 2035

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/75
WIPO fieldBiotechnology
WIPO sectorChemistry

Abstract

Provided are antibodies capable of binding to a particular epitope or specifically binding to LF or LTx and enhancing the activity of the LF or LTx relative to the LF or LTx absent the antibody binding.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.